In English | En español
Questions About Cancer? 1-800-4-CANCER

Featured Clinical Trials

Highlighted NCI-Supported Cancer Studies

Page Options

  • Print This Page
  • Email This Document

Search Featured Trials

Featured Clinical Trials Supported by the National Cancer Institute


Today, thousands of cancer clinical trials are under way in the United States. Clinical trials answer vital research questions that lead to better screening, prevention, diagnosis, and treatment options for all cancers. This section highlights NCI-supported cancer trials and demonstrates the breadth of clinical cancer research supported by the Institute.

To find other cancer trials open to enrollment:

  • Call NCI's Cancer Information Service at 1-800-4-CANCER (1-800-422-6237) for information about trials all across the country. The call is toll-free and completely confidential.
  • Use the clinical trials search form to look online for trials listed on NCI's Cancer.gov website. The form has a Help link for tips about searching for clinical trials.
  • For information about cancer trials taking place on the National Institutes of Health campus in Bethesda, Maryland, call NCI’s Clinical Trials Referral Office at 1-888-NCI-1937 (1-888-624-1937). The call is toll-free and completely confidential.
  • Adjuvant Treatment for Resected Lung Cancer
    (Posted: 08/07/2007) - In this clinical trial, doctors are exploring whether the addition of bevacizumab to adjuvant chemotherapy can help patients with early non-small cell lung cancer (NSCLC) live longer following surgery to remove their tumors.
  • Education and Exercise to Prevent Lymphedema
    (Posted: 07/24/2007) - This study compares a lymphedema-prevention education program to the same education program supplemented with an exercise regimen and counseling in women who have been newly diagnosed with breast cancer and who will undergo axillary node dissection.
  • Immunotherapy for Patients with Metastatic Melanoma
    (Posted: 10/12/2004, Updated: 07/18/2007) - With this trial, researchers are testing the safety and tumor-fighting ability of a new type of immunotherapy agent in patients with metastatic melanoma that has not responded to standard treatment.
  • New Targeted Therapy for Solid Tumors and Lymphomas
    (Posted: 08/10/2004, Updated: 07/18/2007) - In this trial, researchers are trying to determine whether a new chemotherapy agent called 17-DMAG will help prevent cancer cells from growing in patients with solid tumors or lymphomas. The agent inhibits a protein called HSP-90 that is found more often in cancer cells than in normal cells.
  • Immunotherapy for Nonresponsive Solid Tumors
    (Posted: 07/20/2004, Updated: 07/18/2007) - In this phase I trial, researchers are testing the ability of interleukin-7 (IL-7) to stimulate patients' white blood cells to kill cancer cells in solid tumors that have not responded to standard therapies.
< Previous  20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40  Next >